James A. Schoeneck
2016 - DepoMed
In 2016, James A. Schoeneck earned a total compensation of $6.2M as Former President and Chief Executive Officer at DepoMed, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $694,000 |
|---|---|
| Option Awards | $2,308,415 |
| Salary | $787,500 |
| Stock Awards | $2,362,290 |
| Other | $14,865 |
| Total | $6,167,070 |
Schoeneck received $2.4M in stock awards, accounting for 38% of the total pay in 2016.
Schoeneck also received $694K in non-equity incentive plan, $2.3M in option awards, $787.5K in salary and $14.9K in other compensation.
Rankings
In 2016, James A. Schoeneck's compensation ranked 1,148th out of 14,075 executives tracked by ExecPay. In other words, Schoeneck earned more than 91.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,148 out of 14,075 | 92nd |
Division Manufacturing | 388 out of 5,486 | 93rd |
Major group Chemicals And Allied Products | 104 out of 1,900 | 95th |
Industry group Drugs | 68 out of 1,543 | 96th |
Industry Pharmaceutical Preparations | 56 out of 1,173 | 95th |
Source: SEC filing on July 14, 2017.
Schoeneck's colleagues
We found five more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2016.